Biological properties of carrageenan.
D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects; D002351:Carrageenan / Q000633:toxicity; D004195:Disease Models, Animal; D004487:Edema / Q000139:chemically induced; D006099:Granuloma / Q000139:chemically induced; D006168:Guinea Pigs; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000517:prevention & control; D006969:Hypersensitivity, Immediate / Q000517:prevention & control; D007249:Inflammation / Q000139:chemically induced; D007705:Kinins / Q000378:metabolism; D010437:Peptic Ulcer / Q000188:drug therapy; D010998:Pleurisy / Q000139:chemically induced; D011134:Polysaccharides / Q000032:analysis; D051381:Rats; D012624:Seaweed; D013329:Structure-Activity Relationship
D007705:Kinins; D011134:Polysaccharides; D002351:Carrageenan